IN THE NEWS

BOTHELL, WA – Cardiac Science Corporation, a global leader in advanced cardiac monitoring and defibrillation products, announced today that San Diego Project Heart Beat, San Diego County’s public access defibrillation (PAD) program, has again selected Cardiac Science as its preferred provider of Automated External Defibrillators (AEDs).  Under a new agreement, Cardiac Science will continue to provide Powerheart^® AEDs to San Diego Project Heart Beat participants until 2011. 

Since its inception in November 2001, San Diego Project Heart Beat has helped agencies, businesses and organizations across San Diego County deploy more than 3,400 Powerheart AEDs in public places.  In that time, these publicly accessible defibrillators have been used to save 43 lives.    

San Diego Project Heat Beat aims to increase the survivability of Sudden Cardiac Arrest (SCA) throughout San Diego County by making AEDs as common as fire extinguishers in city and county buildings, tourist destinations, schools, businesses, and any public place in which a life can be saved.  According to San Diego Project Heartbeat Officials, since businesses, schools, government buildings, and other public places in San Diego have enrolled with Project Heart Beat and deployed AEDs, more than 75 percent of victims who suffered SCA in San Diego County, outside of a hospital, when an AED was present, have survived. That is up from five percent – the national average – prior to the start of the PAD program.  San Diego Project Heart Beat believes these to be among the highest SCA survival rates for any major city in the country.

“When San Diego Project Heart Beat began in November 2001 we set a goal to place 250 AEDs in the first two years,” said Maureen O’Connor of San Diego Fire-Rescue, the Program Coordinator for Project Heart Beat.  “We exceeded that goal by more than 550 units, since then grass roots support for accessible, affordable defibrillation in San Diego has continued apace.” 

“With so many lives saved, the case for accessible, affordable defibrillation is easy to make,” continued Ms. O’Connor.  “When average citizens can identify the symptoms of SCA, activate the emergency response system, and have access to an easy-to-use AED, we can significantly improve the likelihood of surviving a SCA in our community.  We are proud to have helped create so many heart safe environments in San Diego County, and as more local organizations join with Project Heart Beat to install defibrillators, we are excited to make AEDs even more broadly available.”

On June 29, San Diego-based Ultrastar Cinemas announced plans to begin screening a public service announcement before every film shown on its 93 screens during Summer 2007, to educate its audiences on the significant impact that publicly accessible defibrillation technology can have on Sudden Cardiac Arrest survival rates and to encourage support for the deployment of AEDs in their communities.  Ultrastar is among the first cinema chains in the U.S. to protect its customers with AEDs, having recently deployed AEDs in all of its San Diego and Imperial County locations. 

Cardiac Science has been providing AEDs to San Diego Project Heart Beat participants under a five-year contract that began with the program’s inception. Following the anticipated expiration of this contract, San Diego County invited Cardiac Science and the other major AED manufacturers to enter into a competitive bidding process to determine the optimal AED partner for the City and Project Heart Beat program for another five year term.  Once again, Cardiac Science was chosen to be the preferred vendor for this unique, industry-leading alliance.

“Cardiac Science has worked closely with the Project Heart Beat in San Diego since its inception to build meaningful and widespread public access to advanced, reliable and easy-to-use defibrillators and we are ready to support additional AED deployments for increased levels of protection across the greater San Diego metropolitan area,” said Mike Brode, Cardiac Science’s Director of Strategic Business.  “Cardiac Science is devoted to saving lives and we are particularly inspired by San Diego Project Heart Beat’s success.  We are committed to the continued vitality of this leading program and are truly excited to carry on its work.”

San Diego Project Heart Beat aims to provide its participants with the necessary resources to execute local, on-site, life-saving Public Access Defibrillation (PAD) programs successfully, easily, and affordably.  In practical terms, this includes:

• Medical oversight, including physician validation of training, standards, and procedures;
• American Heart Association’s Heartsaver training in CPR with AED;
• Program Maintenance, including record keeping and data collection;
• Consulting on site selection and deployment;
• Incident management;
• Protection against loss, damage or liability associated with an AED deployment; and
• Preferred pricing for AEDs through Cardiac Science.

For more information, please visit, www.sdprojectheartbeat.com. 

About Powerheart

Powerheart brand automated external defibrillators provide reliable, safe, and easy to use cardiac monitoring and defibrillation technology. Powerheart AEDs feature RHYTHMx™ software which detects abnormal heart rhythms, determines whether they are life-threatening, and only delivers a shock when needed. Powerheart AEDs also feature the patented RescueReady® technology, which automatically tests the device on a frequent basis to ensure continued functionality. Powerheart’s STAR® Biphasic Waveform Technology provides levels of escalating energy customized to the patient.  Powerheart AEDs are used by hospitals, police and fire departments, as well as many public access facilities including major corporations, public agencies, airlines and airports, arenas, schools, hotels, casinos and consumers. For more information about Powerheart, go to www.powerheart.com.

About Cardiac Science

Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick^®, HeartCentrix^®, Powerheart^®, and Quinton^® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

Forward-Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, those relating to Cardiac Science Corporation's future AED sales in Japan, expected shipments of backordered products in the fourth quarter of 2010, and expectations regarding the closing of the transaction with Opto Circuits. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results and performance may vary significantly from those expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks include those more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2009, as updated by subsequent quarterly reports on Form 10-Q. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on Facebook at http://facebook.com/cardiacscience, the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT

For information, contact (media) Anastasia Mironova amironova@cardiacscience.com+1.425.402.2092 | (investors) ir@optoindia.com | +91.80.2852.8088 LOGO: http://www.cardiacscience.com/images/main_logo.gif